Cyro Industries is producing a cleaner acrylic-based multipolymer compound with impurities limited to 60-parts-per-billion.
Some Cyro customers faced ``a new cleanliness standard that is required to enter the Japanese market,'' Stephen Magaziner, business manager for modified acrylics, said at a news conference at the company's Medical Design & Manufacturing West booth in Anaheim.
In response, Cyro enhanced its existing line. A proprietary closed-loop air filtering process monitors production of the new material, permitting Cyrolite G20EF to meet Japanese standards.
``We have one [unidentified] customer using it in Japan,'' Magaziner said. Medical applications include disposable devices for intravenous and blood handling systems.
In addition, Cyro introduced four new versions of acrylic-polycarbonate alloys for applications requiring high-impact strength, said Larry Gabriel, project manager. The original, Cyrex 200, was introduced in 1994.
Now, Cyrex 100 carries an Izod impact strength of 8 foot-pounds per square inch, Cyrex 300 deflects heat as high as 250§ F, Cyrex 400 is an extrusion grade and Cyrex 953 deals with thin-wall and cold temperature requirements.
The Cyrex alloys process 100§ F cooler than PC and 50§ F cooler than PC/ABS, a company release said.
Cyro, based in Rockaway, N.J., operates as a joint venture of Rohm GmbH of Darmstadt, Germany, and Cytec Industries Inc. of West Paterson, N.J.